Neurological disorders identified during treatment of a SARS-cov-2 infection

Shinichi Wada, Yoji Nagasaki, Yoko Arimizu, Masatoshi Shimo, Yuta Matsukuma, Masaki Okamoto, Shinichiro Yoshida, Ikkei Ohashi, Go Hashimoto, Takahiro Kuwashiro, Masahiro Yasaka, Yasushi Okada

Research output: Contribution to journalArticlepeer-review

13 Citations (Scopus)


A 69-year-old man was admitted to our hospital under diagnosis of pneumonia due to severe acute respiratory syndrome-corona virus 2 (SARS-CoV-2) (Day 0). He underwent endotracheal intubation from Day 3. Although his respiratory condition improved and anesthetic drugs were discontinued, no cough reflex was observed despite intubation having been performed until Day 17. His tendon reflexes were also diminished. We suspected that he had developed Guillain-Barré syndrome (GBS), and administered intravenous immunoglobulin from Day 18. The absence of cough reflex improved and extubation was successfully performed on Day 23. Neurological disorders including GBS should be considered when intubated SARS-CoV-2 patients present with a loss of cough reflex during the treatment period.

Original languageEnglish
Pages (from-to)2187-2189
Number of pages3
JournalInternal Medicine
Issue number17
Publication statusPublished - Sept 1 2020
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Internal Medicine


Dive into the research topics of 'Neurological disorders identified during treatment of a SARS-cov-2 infection'. Together they form a unique fingerprint.

Cite this